Glucosamine 625 mg tablets

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

glucosamine hydrochloride, Quantity: 750 mg

Available from:

Aspen Pharma Pty Ltd

INN (International Name):

Glucosamine hydrochloride

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: povidone; calcium phosphate; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3000; iron oxide black

Administration route:

Oral

Class:

Medicine Listed (Export Only)

Therapeutic indications:

Temporary relief of the pain of arthritis. (or) Temporary relief of arthritic pain. [Warning S required] May help reduce joint inflammation associated with arthritis. May help reduce joint swelling associated with arthritis. May help increase joint mobility associated with arthritis. For the management of osteoarthritis leading to temporary relief from joint pain within 3-6 weeks. Provides a concentrated dose of an essential building block, glucosamine, which is a naturally occuring amino sugar. Supplementation with glucosamine helps to replenish the supply of this compound in the body and has been shown to have particular clinical benefits in people suffering from osteoarthritis. Specially developed for the temporary relief of pain in people diagnosed with osteoarthritis.

Product summary:

Visual Identification: ; Container Type: Bottle

Authorization status:

Licence status A

Authorization date:

2012-12-06